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Abstract
Background: It is generally accepted that genetic factors play a role in susceptibility to both
leprosy per se and leprosy type, but only few studies have tempted to quantify this. Estimating the
contribution of genetic factors to clustering of leprosy within families is difficult since these persons
often share the same environment. The first aim of this study was to test which correlation
structure (genetic, household or spatial) gives the best explanation for the distribution of leprosy
patients and seropositive persons and second to quantify the role of genetic factors in the
occurrence of leprosy and seropositivity.
Methods:  The three correlation structures were proposed for population data (n = 560),
collected on a geographically isolated island highly endemic for leprosy, to explain the distribution
of leprosy per se, leprosy type and persons harbouring Mycobacterium leprae-specific antibodies.
Heritability estimates and risk ratios for siblings were calculated to quantify the genetic effect.
Leprosy was clinically diagnosed and specific anti-M. leprae antibodies were measured using ELISA.
Results: For leprosy per se in the total population the genetic correlation structure fitted best. In
the population with relative stable household status (persons under 21 years and above 39 years)
all structures were significant. For multibacillary leprosy (MB) genetic factors seemed more
important than for paucibacillary leprosy. Seropositivity could be explained best by the spatial
model, but the genetic model was also significant. Heritability was 57% for leprosy per se and 31%
for seropositivity.
Conclusion: Genetic factors seem to play an important role in the clustering of patients with a
more advanced form of leprosy, and they could explain more than half of the total phenotypic
variance.
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Background
Leprosy, which annually affects about 700,000 new
patients world wide [1], is a chronic disease caused by
Mycobacterium leprae. It is thought that in endemic areas
many individuals are infected with M. leprae, but only a
few of those infected actually develop the disease [2]. Lep-
rosy manifests itself as a disease spectrum, which for treat-
ment purposes has been divided into two forms:
multibacillary (MB) and paucibacillary (PB) leprosy.
Clustering of leprosy patients within households, neigh-
bourhoods and families has been reported several times
[among others: [3-6]].
The discussion of the role played by genetic factors in the
susceptibility to leprosy is long-standing, but came to
prominence again with the recent identification of certain
susceptibility loci [7-9]. In the past many studies have
been performed on the genetic susceptibility of leprosy,
such as segregation studies to unravel the mode of inher-
itance [10,11] and association studies to identify suscepti-
bility genes [12,13]. Several reviews on this topic have
been written [14,15]. It has been generally accepted that
genetic factors do play a role in susceptibility to both lep-
rosy per se and leprosy type and that probably multiple
genes are involved. Suggestions have been made for a
strong genetic component [16,17], but only few studies
have tempted to quantify this. Wallace, Clayton and Fine
[18] estimated the relative recurrence risk ratio to measure
the genetic effect in Northern Malawi. They suggested that
both genetic and non-genetic factors may play a role in
the susceptibility to leprosy, with host genetics playing a
small but significant role (siblings risk ratio was 2).
Interpretation of leprosy clustering within families or
households is difficult, since those persons may not only
share the same genes but also have close contact and the
same or similar socio-economic circumstances. The main
research question of this study was to test which correla-
tion structure (genetic, household or spatial) gives the
best explanation for the distribution of leprosy patients
and persons harbouring specific anti-M. leprae antibodies
(seropositive persons) in our study population. Further-
more, heritability estimates and the siblings recurrence
risk ratio were calculated to give an indication of the max-
imum contribution of genetic factors to the occurrence of
leprosy and seropositivity. The presence of M. leprae spe-
cific antibodies was used as a marker for leprosy infection,
and was recently identified as a risk factor for MB leprosy
[19]. The study was performed in a geographically iso-
lated island population, that has a strong founder effect as
it was founded by only a few persons about 100 years ago.
Of this unique island population, which was found to be
highly endemic for leprosy during a population survey in
2000 [6], the family structure was unravelled and an
extended pedigree prepared.
Methods
Prior to the study we received ethical clearance from the
Ethical Research Committee of the Hasanuddin Univer-
sity and from the Ministry of Health of the Republic of
Indonesia.
Study population
The study described here was performed on the island
Kembanglemari, which has 634 inhabitants and is situ-
ated in the Flores Sea. The island is part of Pangkep Dis-
trict of South Sulawesi Province in Indonesia and located
268 km from Makassar. The inhabitants originate from
South Sulawesi and belong to the Mandar ethnic group.
Data and sample collection
Clinical data were collected in June 2000. During an active
door-to-door survey 88.3% of the population was exam-
ined for clinical symptoms of leprosy [6]. The diagnosis
was based on the WHO classification. Patients with one
lesion were classified as PB1 and with 2–5 lesions as PB2-
5; patients with more than five lesions and/or with a pos-
itive bacterial index (BI) in at least one of three skin
smears were classified as MB. Persons who reported to
have completed a full course of multi-drug treatment,
without active lesions and skin smear negative, were
marked as patients released from treatment (RFT).
At the same time blood samples were collected of the pop-
ulation above 5 years: 68.1% of the population. Serum
was separated by centrifugation on the same day and kept
frozen until use.
During two subsequent population surveys in April 2002
and April 2003 the parent names of the majority of the
inhabitants were asked. Furthermore, during the survey in
April 2002 interviews were held with elderly people and
leprosy patients about their family structure and ances-
tors. With these data an extended pedigree was prepared.
To determine the occurrence of inbreeding the kinship
coefficient (the probability that two alleles, at a randomly
chosen locus, one chosen randomly from individual i and
one from j are identical by descent) was computed for par-
ents [20].
The longitudes and latitudes of every fifth house were
measured using a hand-held Global Positioning System
(GPS, Garmin, Kansas USA). In Arcview 3.2 (Esri, Califor-
nia USA) the remaining houses were situated between the
geo-referenced houses using a detailed hand-drawn map.
The resulting map was used to prepare a geographical dis-
tance matrix between all inhabitants.
IgM antibody detection
The presence of IgM antibodies to M. leprae phenolic gly-
colypid I (PGL-I) was measured by an enzyme-linkedBMC Medical Genetics 2005, 6:40 http://www.biomedcentral.com/1471-2350/6/40
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immunosorbent assay (ELISA) as described previously
[21] using the natural trisaccharide moiety of PGL-I linked
to bovine serum albumin (NT-P-BSA) as antigen. Serum
was diluted 1:500 and tested in duplo. The optical density
at 450 nm (OD) of each serum sample was calculated by
subtracting the OD value of BSA coated wells from that of
NT-P-BSA coated wells. A positive reference serum on
each plate was used to minimize plate-to-plate variation.
The cut-off value for seropositivity was set at 0.200 [21];
any criterion for setting a cut-off is arbitrary since the dis-
tribution of antibody concentration is unimodal [22].
Statistical analysis
Leprosy prevalence was defined as the proportion of the
sum of leprosy patients and RFT patients over the popula-
tion screened for leprosy in June 2000. Even though it is
not common practice, for the purpose of this particular
research question RFT patients were included in the prev-
alence. Seroprevalence was defined as the proportion of
seropositive persons (including seropositive patients)
over the population screened for antibodies.
A score statistic Q [23]
was used to test clustering of leprosy per se, MB leprosy, PB
leprosy and seropositivity due to genetic, household and
spatial effects. Here zi is the outcome for subject i (1 if
affected and 0 otherwise), πi is the age and sex specific
prevalence and Rij is the genetic, household or spatial cor-
relation for subject i and j. The specific Rij are described
below. In the simple case of πi = 0.5 for all i, the statistic Q
reduces to the sum over concordant pairs (i,j) (for exam-
ple leprosy patient - leprosy patient) of Rij minus the sum
over disconcordant pairs (i,j) (leprosy patient - person
with no leprosy) of Rij. In general the statistic Q tends to
be large when concordant pairs have higher correlations
Rij compared to discordant pairs. For the score test it is
important to realise that healthy persons also provide
information, although not as much as the patients. The
distribution of Q under the null hypothesis of no correla-
tion can be approximated by a chi-square distribution
with scale parameter 0.5Var(Q)/E(Q) and degrees of free-
dom of 2E(Q)2/Var(Q). Formulae for the expectation and
variance of Q can be found in Houwing-Duistermaat et al
[23].
The correlation structures Rij corresponding to the genetic,
household and spatial effects were based on distances
between individuals. For the genetic model correlation
between pairs is based on genetic distances (dg) in the
pedigree; siblings have a higher correlation compared to
cousin-pairs and unrelated persons have no correlation.
Specifically Rij = 1/2dg which is equivalent to two times the
kinship coefficient. In the household model the distances
between individuals sharing the same household is zero
which gives a correlation of 1, and distance infinite for
inhabitants of different households (Rij = 0). The spatial
model is an extension of the household model. The dis-
tance for the spatial model (de) equals the distance
between 2 households in metres. We used the following
formula: Rij = exp(-de
ij/44). In previous studies it was
shown that apart from household contacts also first and
second neighbours have an increased risk of developing
leprosy [5]. The number 44 still gives a good correlation
between a house and its second neighbour: for de = 11
(the mean distance between a house and its nearest (first)
neighbour) Rij = 0.779, for de = 22 (the assumed distance
between house and its second neighbour) Rij = 0.607 and
for de = 33 Rij = 0.473. This last correlation is seen as a
moderate correlation [24]. Thus, the correlation decreases
when the distance between 2 households becomes larger.
We performed a sensitivity analysis in which the number
44 was changed into 33 and 55. Spearman rank correla-
tion coefficients were computed between the correlations
Rij of the different random effects.
In the analysis for leprosy per se all patients detected in
June 2000 and the RFT patients were included. These RFT
patients were excluded from the separate analyses for MB
and PB leprosy, because classification could not be con-
firmed. For leprosy per se the test was, apart from the total
population, also performed on a subpopulation which
was expected to have a relatively stable household status
over the last 20 years, namely the population below 21
and above 39 years. From the data it was seen that up to
the age of 20 84% (291/346) still lived in the same house
as their mother, and that after the age of 20 this percentage
was much smaller (12%; 25/214), indicating that most
people moved when they were around 20 year of age.
Interviews learned that most people move only once in
their life, namely when they get married and move from
their parental house into their own house. Persons aged
21–39 were excluded because it is expected that most of
these persons had a change in household status within the
last 20 years.
Heritability estimates were calculated for leprosy per se
and for seropositivity using a random effects model with
a logit link and assuming Gaussian random effects [25].
The heritability estimates are presented with two-sided
95% confidence intervals (95% CI). The confidence inter-
vals were estimated using profile likelihood. Both the
score statistic and the heritability estimates were adjusted
for the covariates age (continuous) and sex.
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Finally, the risk ratios for siblings (λs) for leprosy per se
and seropositivity, defined as the ratio of the risk of lep-
rosy/seropositivity for siblings of affected persons to the
risk for the general population, were calculated separately
for the group under 21 years and the group of 21 years and
older according to the method described by Olson and
Cordell [26]. Confidence intervals were calculated accord-
ing to the method of Zou and Zhao [27]. Different age
groups were used because the risk of leproys/seropositiv-
ity for the general population (i.e. prevalence) differed
between age groups.
Results
In June 2000 634 persons were living in the 120 houses
on Kembanglemari (average: 5.3 persons per house). Of
the 560 persons screened, 28 were diagnosed with leprosy
(12 were classified as MB, 3 as PB2-5 and 13 as PB1) and
3 persons were identified who had leprosy in the past, but
were released from treatment (Table 1). Of the 432 per-
sons who were tested for antibodies against M. leprae, 37
(8.6%) were seropositive. Two (17%) of the 12 MB
patients, none of the PB patients and none of the RFT
patients were seropositive. Table 2 shows leprosy and
seroprevalence for the different age groups: leprosy was
more prevalent among adults than among children while
seroprevalence was higher among children. No difference
was found between men and women with regard to lep-
rosy (4.9% and 6.1%, respectively, p = 0.52) or seroposi-
tivity (7.4% and 9.6%, respectively, p = 0.41). Figures 1
and 2 show maps of the island with the patients and the
seropositive persons per house, respectively.
Table 1: Characteristics of study population in June 2000
n%
Persons living on Kembanglemari 634
Persons screened for leprosy 560 88.3
Persons screened for antibodies 432 68.1
Persons included in pedigrees 589 92.9
Leprosy status
No leprosy 529 94.5
PB1a leprosy 13 2.3
PB2-5b leprosy 3 0.5
MBc leprosy 12 1.9
RFTd (no classification available) 3 0.5
Serological status
Seronegative 395 91.4
Seropositive 37 8.6
a PB1 = single lesion paucibacillary leprosy
b PB2-5 = paucibacillary leprosy with 2–5 lesions
c MB = multibacillary leprosy
d RFT = released from treatment
Table 2: Leprosy and seroprevalence per agegroup
Age group 
(years)
Screened for 
leprosy
RFTa MB Leprosyb PB Leprosyc Leprosy N (%) Tested for IgM Seropositive N 
(%)
0–5 122 0 0 0 0 7 1 (14.3)
6–20 219 0 4 8 12 (5.5) 211 24 (11.4)
21–39 136 2 5 5 12 (8.8) 133 9 (6.8)
40–59 57 1 3 0 4 (7.0) 55 1 (1.8)
≥60 26 0 0 3 3 (11.5) 26 2 (7.7)
Total 560 3 12 16 31 (5.5) 432 37 (8.6)
a RFT = released from treatment
b MB = multibacillary leprosy
c PB = paucibacillary leprosyBMC Medical Genetics 2005, 6:40 http://www.biomedcentral.com/1471-2350/6/40
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Four families were identified on the island. The pedigrees
included 791 persons in total, of which 589 were living on
the island in June 2000 and 202 persons were parents who
had already died, lived somewhere else or could not be
traced. One pedigree included 568 (89.6%) inhabitants,
all leprosy patients and 35 seropositive persons and con-
sisted of six generations. Figure 3 shows part of this pedi-
gree as an example. Of the 560 persons screened for
leprosy 535 were included in the pedigrees and of the 432
persons who were tested for antibodies 411 were
included. The unrelated single individuals (25 in leprosy
analyses and 21 in seropositivity analyses) were retained
in the analysis as independents.
In total 184 couples with children were counted. Of 79
pairs who were alive in 2000, both parents were known.
Of these, 15 pairs (19%) were genetically related (kinship
coefficient varied between 0.156–0.0156). They had 62
Map of Kembanglemari Island showing the new patients per house Figure 1
Map of Kembanglemari Island showing the new patients per house.   =  0,  ●  = 1,   = 2, + = 3 new patients. Not all 
houses without patients are shown.
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children (56 screened for leprosy, 34 tested for antibod-
ies). None of the children had leprosy and 4 were serop-
ositive (11.8%).
For the total population the test statistic of Houwing-
Duistermaat et al. [23] (results in Table 3) showed that for
leprosy per se and MB leprosy the genetic correlation struc-
ture fitted best (p < 0.001 and p = 0.002, respectively). For
MB leprosy the household model also fitted (p = 0.005).
For PB leprosy neither the genetic nor the household nor
the spatial correlation structure were significant. For sero-
positivity the spatial correlation structure fitted best (p =
0.003), but the genetic model was significant too (p =
0.016). For leprosy per se in the population below 21 and
above 39 years the genetic correlation structure fitted best,
but all structures were significant (p < 0.001 for genetic, p
= 0.002 for household and p = 0.017 for spatial). The sen-
sitivity analysis showed no substantial differences in the
results when using 33 or 55 instead of 44 in the spatial
correlation structure. In the total population, the Spear-
man rank correlation coefficient between the spatial and
genetic correlations was 0.10, between the household and
Map of Kembanglemari Island showing the seropositive persons per house Figure 2
Map of Kembanglemari Island showing the seropositive persons per house.   = 0, ●  = 1,   = 2, + = 3 seropositive 
persons. Not all houses without seropositive persons are shown.
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genetic correlations 0.15, and between the spatial and
household correlations 0.16.
The heritability estimate for leprosy was 0.57 (95% CI:
0.22–0.81) and for seropositivity 0.31 (95% CI: 0–0.71).
The risk ratio for siblings (λS) for leprosy per se in the pop-
ulation below 21 years was 6.4 (95% CI: 0–17.0) and in
the population above 20 years 2.9 (95% CI: 0–9.3). For
seropositivity λS was 1.3 (95% CI: 0–3.0) in the popula-
tion <21 years and 2.7 (95% CI: 0–7.0) in the population
>20 years.
Discussion
Strengths of the study
This study describes a unique island population with a
strong founder effect: 90% of the population belonged to
the same pedigree in which consanguineous marriages
took place and the leprosy prevalence was extremely high
(5.5%). This makes the population very suitable to study
whether genetic effects can explain the distribution of lep-
rosy-related traits within the families.
Principal findings
In the total population clustering of leprosy per se could
only be explained by genetic factors and not by contact
Part of the extended pedigree of family one, showing family relations between leprosy patients Figure 3
Part of the extended pedigree of family one, showing family relations between leprosy patients.
Table 3: P-values for testing the null hypothesis of no clustering of leprosy per se, MB leprosy, PB leprosy and of seropositivity due to 
genetic, household and spatial effects.
Study population 
Trait
N (sero)preve. Genetic Household Spatial
Total population
Leprosy per se 560 5.5% <0.001 0.084 0.145
MBa leprosy 541c 2.2% 0.002 0.005 0.105
PBb leprosy 545d 2.9% 0.311 0.154 0.555
Seropositivity 432 8.6% 0.016 0.118 0.003
Population <21 and >39 years
Leprosy per se 424 4.5% <0.001 0.002 0.017
Test-statistic is adjusted for age and sex.
Italic: p-value <0.05; Bold: best fitting model
a MB = multibacillary leprosy; b PB = paucibacillary leprosy
c 541 = 560 - 3 RFT patients - 16 PB patients
d 545 = 560 - 3 RFT patients - 12 MB patients
e (sero)prev = leprosy prevalence or seroprevalenceBMC Medical Genetics 2005, 6:40 http://www.biomedcentral.com/1471-2350/6/40
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status. In this particular population the heritability of lep-
rosy per se was 57%. For PB leprosy no clustering could be
detected, but for MB leprosy both the genetic and the
household were significant. For seropositivity genetic fac-
tors seemed less important compared to leprosy: the her-
itability of seropositivity was lower, namely 31%, and
although the genetic model was significant, the spatial
model explained the clustering of seropositivity better.
Potential biases
This population-based study included 560 persons of
which 31 were affected with leprosy. Although the total
population is large, and has one of the highest prevalences
of leprosy in the world, the number of leprosy patients is
still rather small. Therefore the confidence intervals of the
heritability and siblings risk ratios are rather large, which
may limit the weight that should be given to the results.
Since the three effects give similar correlation structures in
the data (family members are for example living in the
same house), a significant effect may be a confounder for
one of the other effects [28]. Therefore the heritability esti-
mates may also partly reflect shared environmental
effects. Fortunately the correlations between the structures
appeared to be rather small (≤0.16) indicating only small
overlap between the various effects. The score statistics
indicate which correlation structure fits best to the data.
Thus the heritability estimate of 0.57 for leprosy repre-
sents genetic effects while the heritability of seropositivy
probably also measures spatial effects, since the spatial
correlation structure fitted better to the data than the
genetic correlation structure.
Information bias could have occurred since leprosy
patients were interviewed as a separate group and they
may have had a better insight into their genetic distance to
other leprosy patients. However, since information was
collected in multiple ways, i.e. also by interviewing elderly
persons and through two population surveys, it is
expected that this bias will be minimal.
Household status as well as the distance matrix (used for
the spatial model) were determined at the time of the
screening in June 2000. The household status in 2000
does not necessarily reflect the household status at time of
transmission/infection due to the long incubation time
(estimated to vary between 2 and 12 years [29]). During
this time patients could have moved to different houses.
To overcome this problem we decided to apply the test
statistic for leprosy per se also for the population excluding
those aged between 20 and 40 years. Young adults seem
to move out of their parental house around their 20th
birthday. The 20-year lag time is to take into account the
incubation period and detection delay. We assumed that
within the group younger than 20 and older than 40 years
the household status for most patients would be similar at
time of infection and diagnosis.
Interpretation
In contrast to the results of the general population, where
susceptibility to leprosy per se could only be significantly
explained by genetic factors, among the population below
21 and above 39 years all three correlation structures were
significant. Especially the household and genetic effects
were highly significant in this subgroup, making it more
difficult to distinguish between the effects. Genetically
closely related persons probably live in the same house-
hold for this age group. The smallest p-value for genetic
effects suggests, however, that genetically related individ-
uals living in different households tend to have similar
outcomes and/or distantly related individuals living in the
same household have different outcomes.
When looking separately for MB and PB leprosy in the
total population, MB leprosy appeared to have a genetic as
well as a household effect. However, for PB leprosy clus-
tering could not be detected at all, meaning that it was
randomly spread in the population. The PB group con-
sisted mainly of PB patients with a single lesion (78%).
Part of these PB1 patients may have spontaneously healed
if there had been no active screening [16]. The fact that we
do not have many PB patients with 2 to 5 lesions, could
be due to over-diagnosis of MB patients. In that way it
would be better to describe the MB patients as the patients
with a more advanced form of leprosy. It seems that for
actual progression to a more advanced state of disease
genetic factors become more important.
Although not significant, probably due to small numbers,
a relatively high recurrence risk ratio of 6.4 for siblings for
leprosy per se was found in the population below 21 years,
indicating that brothers/sisters of a patient had a more
than 6 times higher risk of developing leprosy compared
to the general population in that age group. Since in this
young population most of the siblings still live together in
the parental house, the recurrence risk ratio measures also
household effects. In the population above 20 years the
recurrence risk ratio for siblings was 2.9, which is compa-
rable to other studies: in a population in South India a λs
of 2.4 for tuberculoid leprosy [30] and in a population in
Vietnam a λs of 2.21 for leprosy per se [17] has been esti-
mated. The λs for infectious diseases usually lies between
1.5–5 which is much lower than for example for autoim-
mune diseases like type 1 diabetes and multiple sclerosis
with λs between 15–20 [31].
The recurrence risk ratio for siblings measures the excess
risk of siblings of affected persons compared to the popu-
lation risk and could be used for developing rational
screening procedures. However, it is not adjusted for ageBMC Medical Genetics 2005, 6:40 http://www.biomedcentral.com/1471-2350/6/40
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or sex and only uses the information of clustering within
siblings. Moreover within siblings the effect of sharing
households will be relatively large. In contrast, the herita-
bility estimates are based on correlation between all
genetically related subjects and thus also on relatives who
do not share household for example cousin pairs. It esti-
mates the proportion of the genetic variance explaining
the total phenotypic variance in a defined population and
is used to quantify the degree of genetic contribution to
the development of a disease. We found that in the total
population for leprosy per se 57% of the total variance
could be explained by genetic factors. Probably MB lep-
rosy is responsible for most of this, since the genetic effect
was highly significant for MB leprosy but not significant
for PB leprosy. Only one other study, performed in the
Philippines, described a heritability of lepromatous lep-
rosy among men of 80% [32]. However, this relatively
high estimate is only based on siblings and thus the con-
tribution of shared environment to the estimate may be
relatively high.
The distribution of seropositive persons could be
explained best by the spatial model, but the genetic model
was also significant. The household model could not sig-
nificantly explain clustering. A heritability of 31% was
found and in the population below 21 years siblings of
seropositive persons did not have an increased risk to be
seropositive compared to the general young population.
In the population above 20 years the recurrence risk ratio
for siblings was 2.7, which is comparable with that for lep-
rosy per se. It seems that especially in the young popula-
tion genetic factors are less important for seropositivity
than for leprosy, which could be reflected by the high
seroprevalence in the young population. In a recent pub-
lication we showed that living in the vicinity of two sero-
positive patients increased the risk of harbouring
antibodies against M. leprae [33]. It seems that having
contact with an infectious patient is an important factor in
harbouring antibodies, but to develop MB leprosy genetic
factors become more important.
Leprosy and seroprevalence were not significantly
increased among children of genetically related parents.
However, the sample size was rather small (56 and 34
children, respectively), which makes it difficult to draw
conclusions. In our study genetically related parents have
a higher chance to appear in the younger generations of
the pedigree, since in the older generations the correlation
between parents was often unknown. The fact that we
found 15 pairs of related parents, of which three persons
who married a related person also had parents who were
related, indicates that marrying a related person is cus-
tomary on this island. This suggests that also in the older
generations of the family tree inbreeding may have
occurred, which makes this population interesting for
studying recessive genes.
Use of study population for detection of genes
Until now genome scans that are published either studied
the phenotypes leprosy per se [17] or PB leprosy [7]. Here
we showed that in our population genetic factors appear
to be important for advanced forms of leprosy. A logical
next step would be to see which (candidate) genes, such
as the PARK2 and PACRG genes [9], could explain the
genetic effect found in this population. If none of the
already known chromosome regions can explain the
effect, a genome-wide scan could be carried out to detect
new regions.
Conclusion
Since leprosy is thought to spread from person to person,
contact with a leprosy patient is essential for the transmis-
sion of M. leprae. Among many factors that could influ-
ence the development of infection and disease, such as
age, nutritional status and contact with other mycobacte-
ria, genetic factors probably also play a role. In this highly
endemic area for leprosy genetic factors could explain up
to 57% of the total variance. This unique study popula-
tion is very suitable to confirm the role of already known
chromosome regions in controlling leprosy or to search
for new susceptibility loci.
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